In addition, TOP2α is used as a proliferation marker in multiple cancer types, including CRC56,57, and elevated levels of TOP2α expression are associated with metastasis in prostate cancer, pancreatic cancer, and breast cancer58–61. This evidence concerns the gene TOP2A and prostate cancer.